You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 1, January 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Off-Center Fold
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Radiation Therapy
 •Diagnosis
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Breast Erythema and Induration in a 77-Year-Old Woman—Diagnosis

Arch Dermatol. 2006;142:101-106.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Postirradiation morphea.

MICROSCOPIC FINDINGS AND CLINICAL COURSE

Microscopic examination revealed a moderately intense superficial and deep perivascular and interstitial infiltrate composed of lymphocytes and plasma cells. The deep reticular dermis revealed sclerosis of the collagen bundles. The findings were consistent with an inflammatory stage of morphea. Metastatic breast carcinoma was not seen.

At the 2-week follow-up visit, it was observed that the patient’s condition had not improved without treatment. A 3-month course of twice-daily applications of 0.05% diflorasone diacetate cream was then initiated, and marked improvement in the erythema and induration at the biopsy site was noted after 6 weeks. Some residual retraction remained.

DISCUSSION

Postirradiation morphea is a potential complication of supervoltage radiation therapy, with the first major series reported in 1989.1 The incidence is approximately 1 in 500.2-3 Its development does not appear to be dose related,1, 3 with most patients having received traditional doses of supervoltage particulate irradiation (4300-5900 rad [43.0-59.0 Gy]) for breast cancer treatment.4 . . . [Full Text of this Article]


RELATED ARTICLE

Breast Erythema and Induration in a 77-Year-Old Woman—Quiz Case
Denise K. Woo, George D. Reilly, and Rosalie Elenitsas
Arch Dermatol. 2006;142(1):101-106.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.